The CXCL16-CXCR6 axis in glioblastoma modulates T-cell activity in a spatiotemporal context
Tzu-Yi Chia,Leah K. Billingham,Lauren Boland,Joshua L. Katz,Victor A. Arrieta,Jack Shireman,Aurora-Lopez Rosas,Susan L. DeLay,Kaylee Zillinger,Yuheng Geng,Jeandre Kruger,Caylee Silvers,Hanxiang Wang,Gustavo Ignacio Vazquez Cervantes,David Hou,Si Wang,Hanxiao Wan,Adam Sonabend,Peng Zhang,Catalina Lee-Chang,Jason Miska
DOI: https://doi.org/10.3389/fimmu.2023.1331287
IF: 7.3
2024-01-17
Frontiers in Immunology
Abstract:Introduction: Glioblastoma multiforme (GBM) pathobiology is characterized by its significant induction of immunosuppression within the tumor microenvironment, predominantly mediated by immunosuppressive tumor-associated myeloid cells (TAMCs). Myeloid cells play a pivotal role in shaping the GBM microenvironment and influencing immune responses, with direct interactions with effector immune cells critically impacting these processes. Methods: Our study investigates the role of the CXCR6/CXCL16 axis in T-cell myeloid interactions within GBM tissues. We examined the surface expression of CXCL16, revealing its limitation to TAMCs, while microglia release CXCL16 as a cytokine. The study explores how these distinct expression patterns affect T-cell engagement, focusing on the consequences for T-cell function within the tumor environment. Additionally, we assessed the significance of CXCR6 expression in T-cell activation and the initial migration to tumor tissues. Results: Our data demonstrates that CXCL16 surface expression on TAMCs results in predominant T-cell engagement with these cells, leading to impaired T-cell function within the tumor environment. Conversely, our findings highlight the essential role of CXCR6 expression in facilitating T-cell activation and initial migration to tumor tissues. The CXCL16-CXCR6 axis exhibits dualistic characteristics, facilitating the early stages of the T-cell immune response and promoting T-cell infiltration into tumors. However, once inside the tumor, this axis contributes to immunosuppression. Discussion: The dual nature of the CXCL16-CXCR6 axis underscores its potential as a therapeutic target in GBM. However, our results emphasize the importance of carefully considering the timing and context of intervention. While targeting this axis holds promise in combating GBM, the complex interplay between TAMCs, microglia, and T cells suggests that intervention strategies need to be tailored to optimize the balance between promoting antitumor immunity and preventing immunosuppression within the dynamic tumor microenvironment.
immunology